ReviewRevista de neurologia2026
The Dual Role of VEGF in Intracerebral Haemorrhage: From Pathological Mechanisms to Therapeutic Opportunities.
Review in Revista de neurologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An intracerebral haemorrhage (ICH) is a general type of haemorrhage in the brain, which arises due to the rupture of cerebral blood vessels. Many molecules have been investigated for their potential ability to modify hemostasis and blood-brain barrier function in ICH. Vascular endothelial growth factor (VEGF) is highly expressed in some diseases and helps induce angiogenesis. VEGF serves as a key mediator of the angiogenic pathway and is now recognized as a major contributor to cerebrovascular diseases; many promising results have been obtained in animal therapeutic experiments. VEGF promotes blood vessel growth (angiogenesis) to increase oxygen and nutrient supply in damaged tissues, and exerts neuroprotective effects in processes including inflammation, apoptosis, neurotrophy, and protein clearance. This review examines the dual roles of VEGF in the pathology of ICH and explores therapeutic targets of VEGF pathways for this disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.